Page last updated: 2024-09-02

1-hydroxymethylmidazolam and Disorders of Excessive Somnolence

1-hydroxymethylmidazolam has been researched along with Disorders of Excessive Somnolence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bettenhausen, DK; Connolly, M; Forbes, WP; Pentikis, HS; Trapnell, CB	1

Trials

1 trial(s) available for 1-hydroxymethylmidazolam and Disorders of Excessive Somnolence

Article	Year
The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers. Pharmacotherapy, 2007, Volume: 27, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anti-Infective Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Intestines; Liver; Male; Midazolam; Middle Aged; Rifamycins; Rifaximin	2007

Article

Year

The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.

Pharmacotherapy, 2007, Volume: 27, Issue:10

Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anti-Infective Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Intestines; Liver; Male; Midazolam; Middle Aged; Rifamycins; Rifaximin

2007